Michael Milligan

Connecticut Innovations, Inc (CI) is venture capital firm founded in 1989. The firm is headquartered in Rocky Hill, Connecticut.

CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT.

Shionogi Pharma, Inc. manufactures pharmaceuticals. The company is headquartered in Alpharetta, GA.

BioRez, Inc. engages in the design and development of resorbable polymer scaffold technology. The firm offers a device that is suited for tendon, ligament, and other soft tissue injuries. The company was founded by Cato T. Laurencin and Joseph W. Reilly in 2008 and is headquartered in New Haven, CT.

FMP Products, Inc. designs, manufactures and sells laboratory automation equipment to pharmaceutical companies. Its products include 3D digital video microscope with automated xyz stage and servo controlled micro manipulators. The company was founded by Thomas J. Friedlander And Walter Meltzer in 2005 and is headquartered in Danbury, CT.

EpiEP, Inc. develops heart-related medical devices. It has developed epicardial access system, EpiAccess, which engages a patent protected pressure-guided needle that is designed to alert physicians of needle tip location during epicardial access procedures. The firm specializes on instruments that facilitates an epicardial approach for patients who benefit from minimally invasive procedures on the surface of the heart. The company was founded by Pamela M. Bunes, Jason Tucker-Schwartz, Srijoy Mahapatra and George T. Gillies in December 2008 and is headquartered in New Haven, CT.

Prevention Pharmaceuticals, Inc. manufactures pharmaceutical products. The private company is based in New Haven, CT. The company was founded by Harry H. Penner.

P2 Science, Inc. operates as a specialty chemical biorefinery company. It offers cosmetics and personal care, flavors and fragrances, specialty materials, and bioactives. The company was founded by Neil A. Burns, Paul Anastas, and Patrick Foley in 2011 and is headquartered in Woodbridge, CT.

SAMI Health, Inc. provides healthcare information technology services. It is developing information solutions for hospitals and other healthcare institutions. The company was founded by Richard R. Rakowski and Matt Walton in 2012 and is headquartered in Westport, CT.

Synbody Biotechnology, Inc. operates as a platform for the discovery and development of novel and attractive molecules. The company was founded by Paul L. Hallenbeck, Chris Diehnelt, Kevin D. Burroughs and Stephen Albert Johnston in 2010 and is headquartered in Chester Springs, PA.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Baptist Hospital (Tennessee) provides healthcare services. The company offers services in the areas of cancer, cardiac, and diabetes. Its services include rehabilitation and childbirth services. Baptist Hospital was founded in 1918 and is headquartered in Nashville, TN.

Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT.

Ikonisys, Inc. designs and manufactures medical diagnostic products for the diagnosis of cancers. Its products include Ikoniscope Robotic Microscope that provides automated slide handling, slide scanning, real-time image capture and analysis, eliminates various factors that cause human error in testing, oncoFISH bladder that allows scanning and analysis of cells recovered from a voided urine sample. The company was founded by Pramod K. Srivastava, Petros Tsipouras, Gamil G. de Chadarevian, Michael W. Kilpatrick and Triantafyllos Tafas in 1999 and is headquartered in New Haven, CT.

EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA.

Connecticut Business & Industry Association is a non-profit organization that provides commercial support services. The private company is based in Hartford, CT. Joseph F. Brennan has been the CEO of the company since 1988.

RxGen, Inc. operates as a translational research company. It specializes in the fields of ophthalmology, central nervous system, cardiovascular and metabolic related disease and disorders, and have advanced discovery and development. The company was founded by Christopher M. Stanley, Steven R. Gullans and Harry H. Penner, Jr. and is headquartered in Manhattan Beach, CA.

MAKScientific LLC develops drugs to treat medical disorders by modulating the endocannabinoid system. The firm discovers medications for metabolic disorders, pain, addiction, and neurological diseases. The company was founded by Alexandros Makriyannis in 2004 and is headquartered in Mystic, CT.

AlloMek Therapeutics LLC develops and discovers pharmaceutical products for cancer therapies. It offers MEK kinase inhibitors that improve the biopharmaceutical properties of previous MEK inhibitors. The company was founded by Khire R. Uday and Barry Hart in 2010 and is headquartered in Farmington, CT.

Tangen Biosciences, Inc. develops portable instruments and methods for use in molecular diagnostics. Its instrument provides rapid nucleic acid detection, with the specificity and sensitivity of polymerase chain reaction amplification. The company was founded by John R. Nobile and John Davidson in 2013 and is headquartered in Branford, CT.

CaroGen Corp. operates as a vaccine company. It creates and develops virus-like-vesicle based nanoparticle vaccines to address a broad range of infectious and chronic diseases. The company was founded by Bijan Almassian, John Rose, Michael Robek and Valerian Nakaar on November 16, 2012 and is headquartered in Hamden, CT.

QCDx LLC engages in the design, manufacture, and marketing of instruments, consumables, and reagents for the detection of rare cells in the blood circulation. The company was founded by Triantafyllos Tafas and Harry H. Penner in 2017 and is headquartered in Farmington, CT.